Prelude Therapeutics Incorporated
BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

Last updated:

Abstract:

The present disclosure provides bifunctional compounds comprising a target protein binding moiety and a E3 ubiquitin ligase binding moiety, and associated methods of use.

Status:
Application
Type:

Utility

Filling date:

9 Jun 2021

Issue date:

3 Feb 2022